Feasibility and Efficacy of Cognitive-Behavioral Therapy for Patients With ADHD/Behavioral Addiction Comorbidity

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity Hospital, Tours

About this trial

The main objective of this pilot study is to assess preliminary data on the feasibility of CBT and its evaluation in a randomised trial in patients with co-occurring ADHD and behavioural addiction: Evaluation and comparison of the 12-week retention rate of patients randomised to CBT compared with patients in the 'treatment as usual' control arm.

In order to meet the objective, the patient will take part in a standardized assessment, followed by a therapeutic intervention and a new standardized assessment after the intervention. The standardized assessment consists as follows :

* firstly, 7 self-questionnaires to be completed by the patient, lasting around 45 min, aimed at assessing his or her socio-demographic data; current symptoms, quality of life and functional impact related to ADHD; impulsivity, emotion regulation and assessment of possible anxiety-depressive disorders. * Then the patient will follow the 10 session of cognitivo behavioural psychotherapy. * At 12-weeks post-inclusion, an assessment visit is carried out during which a battery of tests will be administered. This is followed by a research interview with a professional, aimed at gathering his or her experiences.

Eligibility criteria

Qualifiers

Patient over 18 (age ≥ 18 years)

Patient treated in an outpatient addictology department at the CHU of Brest, Nantes or Tours and presenting an ADHD/behavioral addiction comorbidity

Patient affiliated to a social security scheme

For patients treated with methylphenidate: no change in treatment dosage during the previous three months.

Disqualifiers

Patients with psychotic disorders (assessed by clinician)

Pregnant or breast-feeding women

Patients under protective supervision (guardianship or curatorship)

Persons under court protection

Trial design

Treatments tested in this trial

  • Cognitive behavioral therapy

Treatment groups

54 Participants
are divided into 2 treatment groups

Locations

3
CHU La Cavale Blanche Brest France
Centre Hospitalier Saint Jacques Nantes France
CHRU De Tours Tours France

Sponsors and collaborators

University Hospital, Tours

Lead sponsor

Nantes University Hospital

Collaborator

University Hospital, Brest

Collaborator